http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004147802-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0291
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M60-859
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M60-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M60-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M60-148
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-12
filingDate 2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7980cfa923a37b96428223ae0dc28d2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ff7852a1d5d179f817784da91a6edaf
publicationDate 2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004147802-A1
titleOfInvention Staged implantation of ventricular assist devices
abstract An implantation regime for a ventricular assist device (VAD) comprising implanting a first VAD ( 13 ) intended for short term use for a predetermined period of time and then determining whether the heart can operate without further assistance after this period of time. A second VAD ( 30 ) intended for long term use may then be implanted if necessary. Also disclosed are percutaneous leads ( 40 ) that have surface treatments ( 45, 47 ) to enable tissue ingrowth in certain areas and prevent tissue ingrowth in other areas, and an embolisation device ( 21, 22 ) carrying a coagulating material ( 27 ) for sealing an implanted cannula ( 15, 16 ) between the use of the first and second VADs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9694122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8540618-B2
priorityDate 2001-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6554851-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5989215-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5626562-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5219361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5755762-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5941813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5879375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4995857-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7048710-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6511413-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6264601-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238

Total number of triples: 32.